IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
706.94
+24.71 (3.62%)
Jan 6, 2026, 3:35 PM EST - Market open
IDEXX Laboratories Employees
IDEXX Laboratories had 11,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
11,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$378,856
Profits / Employee
$93,402
Market Cap
56.45B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11,000 | 0 | - |
| Dec 31, 2023 | 11,000 | 220 | 2.04% |
| Dec 31, 2022 | 10,780 | 430 | 4.15% |
| Dec 31, 2021 | 10,350 | 1,050 | 11.29% |
| Dec 31, 2020 | 9,300 | 100 | 1.09% |
| Dec 31, 2019 | 9,200 | 823 | 9.82% |
| Dec 31, 2018 | 8,377 | 777 | 10.22% |
| Dec 31, 2017 | 7,600 | 235 | 3.19% |
| Dec 31, 2016 | 7,365 | 565 | 8.31% |
| Dec 31, 2015 | 6,800 | 400 | 6.25% |
| Dec 31, 2014 | 6,400 | 700 | 12.28% |
| Dec 31, 2013 | 5,700 | 300 | 5.56% |
| Dec 31, 2012 | 5,400 | 300 | 5.88% |
| Dec 31, 2011 | 5,100 | 300 | 6.25% |
| Dec 31, 2010 | 4,800 | 0 | - |
| Dec 31, 2009 | 4,800 | 100 | 2.13% |
| Dec 31, 2008 | 4,700 | 0 | - |
| Dec 31, 2007 | 4,700 | 800 | 20.51% |
| Dec 31, 2006 | 3,900 | 600 | 18.18% |
| Dec 31, 2005 | 3,300 | 305 | 10.18% |
| Dec 31, 2004 | 2,995 | 522 | 21.11% |
| Dec 31, 2003 | 2,473 | 292 | 13.39% |
| Dec 31, 2002 | 2,181 | 11 | 0.51% |
| Dec 31, 2001 | 2,170 | -80 | -3.56% |
| Dec 31, 2000 | 2,250 | 200 | 9.76% |
| Dec 31, 1999 | 2,050 | -50 | -2.38% |
| Dec 31, 1998 | 2,100 | 0 | - |
| Dec 31, 1997 | 2,100 | 585 | 38.61% |
| Dec 31, 1996 | 1,515 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IDXX News
- 6 weeks ago - IDEXX Laboratories Vs ResMed: Which Stock Could Rally? - Forbes
- 7 weeks ago - Baron Asset Fund Q3 2025 Performance Review - Seeking Alpha
- 2 months ago - IDEXX Laboratories: A Strong Third Quarter With Good Future Prospects - Seeking Alpha
- 2 months ago - IDEXX Laboratories, Inc. (IDXX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Idexx Stock Pops on Earnings. Pet Health Is Booming. - Barrons
- 2 months ago - Idexx Laboratories Extends Rally Following Upbeat Q3 Earnings, Outlook - Benzinga
- 2 months ago - IDEXX raises annual forecasts as pet owners spend more on preventive care - Reuters
- 2 months ago - IDEXX Laboratories Announces Third Quarter Results - Business Wire